Ballarat Health Services   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Ballarat Australia (1997)

Organization Overview

First Clinical Trial
2008
NCT00784667
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Ballarat Health Services

Active Ingredients

Drugs in Phase 4 Trials (1)

normoxocin (1 trial)

Drugs in Phase 3 Trials (1)

tanezumab (1 trial)

Drugs in Phase 2 Trials (4)

atezolizumab (tecentriq) (1 trial)

cetuximab (erbitux) (1 trial)

erlotinib (tarceva) (1 trial)

obinutuzumab (gazyva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Colorectal Neoplasms (Phase 2)

Musculoskeletal Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6